Want to see HK:2273 full AI Analyst Report?
2273 Stock Chart & Stats
HK$29.00
HK$0.95(3.47%)
At close: 4:00 PM EST
HK$29.00
HK$0.95(3.47%)
Day’s Range― - ―
52-Week RangeHK$24.32 - HK$38.30
Previous CloseN/A
Volume1.49M
Average Volume (3M)1.54M
Market Cap
HK$7.44B
Enterprise ValueHK$4.83B
Total Cash (Recent Filing)HK$1.15B
Total Debt (Recent Filing)HK$784.51M
Price to Earnings (P/E)17.5
Beta1.26
Next Earnings
Aug 25, 2026EPS Estimate
0.87Next Dividend Ex-DateN/A
Dividend Yield2.61%
Share Statistics
EPS (TTM)1.49
Shares Outstanding234,371,050
10 Day Avg. Volume1,228,922
30 Day Avg. Volume1,539,754
Financial Highlights & Ratios
PEG Ratio0.93
Price to Book (P/B)2.84
Price to Sales (P/S)1.90
P/FCF Ratio12.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$39.44Price Target Upside36.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)1.81
Revenue Forecast (FY)HK$3.77B
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Sustained ProfitabilityRevenue expanded meaningfully (2025 ~40% after ~30% in 2024) and the company returned to steady net profit margins (~10–11%) after the 2021 loss. Durable top-line momentum with consistent profitability supports reinvestment, scale benefits and long-term cash generation.
Cash Generation ResilienceHistorically positive free cash flow and an FCF-to-net-income ratio near 0.8 provide internal funding for capex, working capital and dividends. Persistent positive cash generation across multiple years underpins financial flexibility and reduces reliance on external financing for core investments.
Defensible TCM Service ModelOwning a network of TCM clinics with both consultation fees and dispensary sales creates recurring patient flows and cross-sell economics. This vertically integrated service model supports steady demand, repeat revenue and margin capture from both services and product dispensing over the medium term.
Bears Say
Margin VolatilityEBITDA and gross margin swings (notably weaker in 2024) indicate sensitivity to cost mix, pricing or operating leverage. Persistent margin volatility can erode sustainable profitability, complicate forecasting, and limit the company's ability to fund strategic initiatives from operating earnings alone.
Rising Leverage In 2025Debt has increased into 2025, raising leverage despite a moderate 2025 debt/equity (~0.36). A rising debt trend reduces financial flexibility, increases interest exposure, and heightens refinancing and covenant risk if operating performance softens, constraining capital allocation choices.
Weak OCF Coverage & FCF ShockA sharp drop in FCF growth in 2025 and operating-cashflow that covers only ~50–60% of accounting earnings point to working-capital timing or cash conversion issues. These cash-flow weaknesses can force external funding, limit reinvestment, and pressure dividends or debt servicing capacity.
Gushengtang Holdings Limited News
2273 FAQ
What was Gushengtang Holdings Limited’s price range in the past 12 months?
Gushengtang Holdings Limited lowest stock price was HK$24.32 and its highest was HK$38.30 in the past 12 months.
What is Gushengtang Holdings Limited’s market cap?
Gushengtang Holdings Limited’s market cap is HK$7.44B.
When is Gushengtang Holdings Limited’s upcoming earnings report date?
Gushengtang Holdings Limited’s upcoming earnings report date is Aug 25, 2026 which is in 38 days.
How were Gushengtang Holdings Limited’s earnings last quarter?
Gushengtang Holdings Limited released its earnings results on Mar 31, 2026. The company reported HK$1.124 earnings per share for the quarter, beating the consensus estimate of HK$1.079 by HK$0.046.
Is Gushengtang Holdings Limited overvalued?
According to Wall Street analysts Gushengtang Holdings Limited’s price is currently Undervalued.
Does Gushengtang Holdings Limited pay dividends?
Gushengtang Holdings Limited pays a Quarterly dividend of HK$0.69 which represents an annual dividend yield of 2.61%. See more information on Gushengtang Holdings Limited dividends here
What is Gushengtang Holdings Limited’s EPS estimate?
Gushengtang Holdings Limited’s EPS estimate is 0.87.
How many shares outstanding does Gushengtang Holdings Limited have?
Gushengtang Holdings Limited has 234,371,050 shares outstanding.
What happened to Gushengtang Holdings Limited’s price movement after its last earnings report?
Gushengtang Holdings Limited reported an EPS of HK$1.124 in its last earnings report, beating expectations of HK$1.079. Following the earnings report the stock price went down -0.513%.
Which hedge fund is a major shareholder of Gushengtang Holdings Limited?
Currently, no hedge funds are holding shares in HK:2273
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gushengtang Holdings Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.49%
12-Months-Change
Fundamentals
Return on Equity
15.51%
Trailing 12-Months
Asset Growth
14.29%
Trailing 12-Months
Company Description
Gushengtang Holdings Limited
Gushengtang Holdings Limited, an investment holding company, provides healthcare services in the People’s Republic of China. The company offers consultation, traditional massage, moxibustion, acupuncture, and other therapies. It is also involved in the wholesale of pharmaceutical products; and provision of investment management and supply chain management services. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. The company was founded in 2010 and is headquartered in Guangzhou, the People’s Republic of China.
2273 Stock 12 Month Forecast
Average Price Target
HK$39.44
▲(36.01% Upside)
Technical Analysis
Beauty Farm Medical & Health Industry, Inc.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Arrail Group Ltd.
―